Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 20Recruiting 11Unknown 6Terminated 5Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 13Brain Neoplasms 9Prostatic Neoplasms 7Neoplasms 7Head and Neck Neoplasms 6Motor Activity 4Glioma 4Glioblastoma 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Colorectal Neoplasms 3Quality of Life 2Papillomavirus Infections 2Pancreatic Neoplasms 2Obesity 2Multiple Myeloma 2Melanoma 2Lymphoma, Follicular 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Cancer Pain 2Biliary Tract Neoplasms 2Behavior 2Weight Loss 1Venous Thromboembolism 1Ureteral Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Suspended × Peritoneal Neoplasms × Clear all
NCT04929015 2026-05-04

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

Rutgers, The State University of New Jersey

Phase NA Suspended
30 enrolled
GastrointestinalGynecologic

Digestive System Neoplasms, Carcinoma, Hepatocellular, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡